Your browser doesn't support javascript.
loading
Combination of traditional Chinese medicine and epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of non-small cell lung cancer: A systematic review and meta-analysis.
Sui, Xinbing; Zhang, Mingming; Han, Xuemeng; Zhang, Ruonan; Chen, Liuxi; Liu, Ying; Xiang, Yu; Xie, Tian.
Afiliación
  • Sui X; Holistic Integrative Pharmacy Institutes and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, College of Medicine, Hangzhou Normal University.
  • Zhang M; Zhejiang Key Laboratory of Elemene Anticancer Traditional Chinese Medicine, Hangzhou Normal University, Zhejiang Provincial Engineering Laboratory of Traditional Chinese Medicine Development and Application, Hangzhou, Zhejiang.
  • Han X; Holistic Integrative Pharmacy Institutes and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, College of Medicine, Hangzhou Normal University.
  • Zhang R; Zhejiang Key Laboratory of Elemene Anticancer Traditional Chinese Medicine, Hangzhou Normal University, Zhejiang Provincial Engineering Laboratory of Traditional Chinese Medicine Development and Application, Hangzhou, Zhejiang.
  • Chen L; Holistic Integrative Pharmacy Institutes and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, College of Medicine, Hangzhou Normal University.
  • Liu Y; Zhejiang Key Laboratory of Elemene Anticancer Traditional Chinese Medicine, Hangzhou Normal University, Zhejiang Provincial Engineering Laboratory of Traditional Chinese Medicine Development and Application, Hangzhou, Zhejiang.
  • Xiang Y; Holistic Integrative Pharmacy Institutes and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, College of Medicine, Hangzhou Normal University.
  • Xie T; Zhejiang Key Laboratory of Elemene Anticancer Traditional Chinese Medicine, Hangzhou Normal University, Zhejiang Provincial Engineering Laboratory of Traditional Chinese Medicine Development and Application, Hangzhou, Zhejiang.
Medicine (Baltimore) ; 99(32): e20683, 2020 Aug 07.
Article en En | MEDLINE | ID: mdl-32769861
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Proteínas Quinasas / Receptores ErbB / Neoplasias Pulmonares / Medicina Tradicional China Tipo de estudio: Clinical_trials / Diagnostic_studies / Systematic_reviews Aspecto: Ethics Límite: Humans Idioma: En Revista: Medicine (Baltimore) Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Proteínas Quinasas / Receptores ErbB / Neoplasias Pulmonares / Medicina Tradicional China Tipo de estudio: Clinical_trials / Diagnostic_studies / Systematic_reviews Aspecto: Ethics Límite: Humans Idioma: En Revista: Medicine (Baltimore) Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos